Literature DB >> 2278865

Flosequinan for congestive heart failure: what promise does it hold?

J R Hampton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2278865     DOI: 10.1007/bf02018256

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  8 in total

1.  The pharmacokinetics and haemodynamics of BTS 49 465 and its major metabolite in healthy volunteers.

Authors:  R D Wynne; E L Crampton; I D Hind
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  The effects of BTS 49465 on blood pressure and peripheral arteriolar and venous tone in normal volunteers.

Authors:  A J Cowley; R D Wynne; J R Hampton
Journal:  J Hypertens Suppl       Date:  1984-12

3.  Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.

Authors:  A J Cowley; R D Wynne; K Stainer; L Fullwood; J M Rowley; J R Hampton
Journal:  BMJ       Date:  1988-07-16

4.  Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failure.

Authors:  P D Kessler; M Packer
Journal:  Am Heart J       Date:  1987-01       Impact factor: 4.749

5.  Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats.

Authors:  M F Sim; D B Yates; R Parkinson; M J Cooling
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

6.  Flosequinan as a third agent for the treatment of hypertension: a placebo controlled, double-blind study.

Authors:  A J Cowley; R D Wynne; J R Hampton
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Effect of flosequinan on exercise capacity and symptoms in severe heart failure.

Authors:  J S Elborn; C F Stanford; D P Nicholls
Journal:  Br Heart J       Date:  1989-04

8.  Central and regional hemodynamic effects of flosequinan for congestive heart failure.

Authors:  G J Haas; P F Binkley; J A Carpenter; C V Leier
Journal:  Am J Cardiol       Date:  1989-06-01       Impact factor: 2.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.